This episode traces the history and science behind triple antibiotic ointment—its three ingredients (bacitracin, neomycin, polymyxin B), how they attack different bacteria, and why it became a household staple for minor cuts.

It explains why diabetic foot ulcers are fundamentally different from everyday wounds—driven by neuropathy, poor blood flow, chronic inflammation, biofilm, and deeper infection—and why a topical ointment cannot address these underlying problems.

The episode also covers risks of using ointment on diabetic ulcers (maceration, contact dermatitis, altered wound microbiome), the difference between colonization and infection, and the importance of prompt medical assessment, vascular evaluation, offloading, debridement, glucose control, and specialized wound care.

Episode Title:

Episode Summary:

What if one of the simplest tools in diabetic foot care could help prevent devastating complications before they happen?

In this powerful episode of LIMBWatch on Diabetic Foot Files, Dr. Gabrielle Donaldson sits down with Dr. Thomas Hardiman, a podiatric surgeon with over 40 years of experience in foot and ankle care and a pioneer in diabetic foot screening through his work with medical monofilament technology.

Together, they take a deep dive into the science, history, and clinical importance of the 10-gram monofilament examination — a simple yet powerful tool used to identify loss of protective sensation (LOPS) and help recognize patients at risk for diabetic foot ulcers and amputations.

Dr. Hardiman reveals the fascinating story behind the development of the monofilament, from early sensory testing pioneers to the influence of Dr. Paul Brand’s groundbreaking work, and explains why prevention starts by “going upstream” rather than waiting until patients present with wounds.

In this episode, you’ll learn:

🦶 How the 10-gram monofilament actually works and what is happening at the nerve level when sensation is lost

Dr. Hardiman shares unforgettable clinical lessons, including a patient whose heel ulcer repeatedly returned because a nail hidden inside his shoe was causing repeated trauma — a reminder that sometimes the most important diagnostic tools are simply looking, listening, and paying attention.

He also challenges the healthcare community to rethink the phrase “silent epidemic,” explaining why diabetic foot complications are not silent and why calling them that may unintentionally create acceptance instead of urgency.

His message to patients is clear:

“Your feet should last a lifetime, and with proper care, they can.”

This episode is a reminder that limb preservation does not always begin with the newest technology. Sometimes it begins with mastering the fundamentals, performing them consistently, and empowering patients before the first ulcer ever develops.

Join us for an eye-opening conversation about neuropathy, prevention, screening, and the simple test that can help change the future of diabetic limb health.

Key Takeaway Quote:

🦶 A 10-gram filament can change the future of a limb.

Before a diabetic foot ulcer appears, there may be a silent warning sign: loss of protective sensation.

Dr. Hardiman, Medical Director of Medical Monofilament, explains why proper monofilament testing matters — helping clinicians identify the “foot at risk” and take action before a small problem becomes a devastating complication.

The right tool. The right technique. The right time.

Learn more about Medical Monofilament technology:

This episode explores why pain evolved as a critical protective alarm and how diabetes—through chronic high glucose, inflammation, and microvascular damage—silences that alarm by injuring peripheral nerves.

It explains the biological pathways behind diabetic neuropathy, why the feet are especially vulnerable, how repetitive pressure and biofilm-forming bacteria turn painless injuries into ulcers, and the stepwise cascade from nerve damage to amputation.

The episode emphasizes prevention and the clinician’s role as an external warning system: early screening, offloading, proper footwear, glucose control, vascular assessment and coordinated limb-salvage care to protect patients’ feet.

This episode explains gossypiboma (retained surgical sponge), how the body mounts a foreign‑body granuloma response, and why these sponges can mimic infection or tumors and lead to chronic inflammation.

It highlights the added danger for people with diabetes (impaired immunity, poor circulation, neuropathy), shares a real diagnostic case, and reviews prevention steps like sponge counts, radiopaque markers, barcode systems, and surgical timeouts. The key message: persistent non‑healing wounds often need a detective approach to look beneath the surface.

Melioidosis is an infection caused by the soil and water bacterium Burkholderia pseudomallei that can enter through cuts, wounds, or inhalation. It often mimics common conditions—pneumonia, tuberculosis, routine wound infections, or chronic diabetic foot infections—making diagnosis challenging.

People with diabetes are at higher risk, and proper diagnosis requires culture and targeted therapy (IV intensive antibiotics such as ceftazidime or meropenem followed by prolonged oral eradication therapy). Prevention focuses on reducing soil and water exposure, protective footwear, wound care, and detailed environmental history for at-risk patients.

The below-the-knee amputation (BKA) is a common major limb loss in people with diabetes, resulting from a long pathway of neuropathy, vascular disease, biomechanical breakdown, ulcers, and infection. Modern amputation philosophy focuses on preserving the knee to maximize function, but BKA remains a marker of advanced systemic disease with significant morbidity and mortality.

Preserving the knee improves mobility, energy efficiency, and prosthetic outcomes; yet prevention is crucial. Early screening, offloading, wound care, vascular assessment, and multidisciplinary limb-salvage teams—especially podiatrists working with vascular and infectious disease specialists—are key to stopping the progression that leads to amputation.

LIMBWatch Series | Dr. Paula DeJesus DPM, FACFAS, : The Future of Limb Salvage Through Minimally Invasive Surgery

Dr. G examines how diabetic toes and ulcers are rarely just wounds but visible warnings of neuropathy, poor circulation, infection, and gaps in care. She asks who is responsible for protecting the foot — the patient, primary care, podiatry, vascular, infectious disease, surgery, or nursing — and how fragmented referrals and delayed access can lead to a cascade ending in amputation.

The episode also explains hospital handling of amputated tissue, patients’ rights to their removed parts, and the future of limb preservation through surveillance technologies and coordinated responsibility to prevent avoidable loss.

This episode introduces edge trenching, a novel debridement technique developed by Dr. Igor Melnichuk that targets dysfunctional wound edges (epibolies, hyperkeratosis, rolled or fibrotic margins) to create a biologically active transition zone and promote epithelial migration.

It explains the procedure, proposed mechanisms, clinical use—especially in diabetic plantar ulcers—how trenches are created and repeated, and emphasizes that edge trenching must be part of comprehensive care addressing perfusion, infection control, offloading, and underlying causes.

Dr. Giulia Baldazzi, a vascular surgeon, fellow and phd candidate researcher, shares her journey from UCSF to Italy and explores advances in perfusion assessment, revascularization, and limb preservation for diabetic foot care.

She discusses diagnostic innovations (PAT, MaxCORE, NIRS), the importance of early vascular referral and multidisciplinary teams, and practical strategies to prevent amputations and improve healing.